June 14, 2019

Claude Knight v. Boehringer Ingelheim

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. January 06, 2021

    4th Circ. Undoes $1.25M Verdict In Pradaxa Suit

    The Fourth Circuit on Wednesday reversed a $1.25 million verdict against Boehringer Ingelheim in a suit over the bleeding risks of its blood thinner Pradaxa, finding that fraud claims brought by the family of a deceased woman were preempted by federal law.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login